Cross-licensing agreement brings reformulated rimiducid to cell and gene therapies, with implications for oncology and longevity medicine.

longevity.technology/news/phoenix...

#longevity #celltherapy #genetherapy #safetyswitch #rimiducid #biotechinnovation #MDAnderson #PhoenixSENOLYTIX

MD Anderson and Phoenix SENOLYTIX in Cross-Licensing Deal to Advance Cell and Gene Therapies - OncoDaily MD Anderson and Phoenix SENOLYTIX in Cross-Licensing Deal to Advance Cell and Gene Therapies / cancer, CaspaCIDe, Dual Switch, GoCAR-T, GoDCVaX, GoTCR, Katy

MD Anderson and Phoenix SENOLYTIX in Cross-Licensing Deal to Advance Cell and Gene Therapies

@mdanderson.bsky.social

oncodaily.com/insight/md-a...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MDAnderson #PhoenixSENOLYTIX #CellTherapy #GeneTherapy